[HTML][HTML] The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri… - The Lancet, 2022 - thelancet.com
Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …
the face of European hepatology is changing due to the cure of viral hepatitis C and the …
Hepatocellular carcinoma surveillance—Utilization, barriers and the impact of changing aetiology
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
Detecting liver cancer using cell-free DNA fragmentomes
ZH Foda, AV Annapragada, K Boyapati, DC Bruhm… - Cancer discovery, 2023 - AACR
Liver cancer is a major cause of cancer mortality worldwide. Screening individuals at high
risk, including those with cirrhosis and viral hepatitis, provides an avenue for improved …
risk, including those with cirrhosis and viral hepatitis, provides an avenue for improved …
Barriers to surveillance for hepatocellular carcinoma in a multicenter cohort
Importance Hepatocellular carcinoma (HCC) surveillance is underused in clinical practice,
which may be owing to patient and clinician barriers. Objective To characterize HCC …
which may be owing to patient and clinician barriers. Objective To characterize HCC …
HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort
Y Tanaka, E Ogawa, CF Huang, H Toyoda… - Hepatology …, 2020 - Springer
Background Despite HCV cure, patients remain at risk for HCC, but risk factor data for HCC
following SVR are limited for Asian patients. Methods To address this gap, we analyzed …
following SVR are limited for Asian patients. Methods To address this gap, we analyzed …
Real-world effectiveness from the Asia Pacific Rim Liver Consortium for HBV risk score for the prediction of hepatocellular carcinoma in chronic hepatitis B patients …
Background Patients on oral antiviral (OAV) therapy remain at hepatocellular carcinoma
(HCC) risk. Risk prediction tools distinguishing treated patients with residual HCC risk are …
(HCC) risk. Risk prediction tools distinguishing treated patients with residual HCC risk are …
Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication
Background & Aims Successful treatment of chronic hepatitis C with oral direct-acting
antivirals (DAAs) leads to virological cure, however, the subsequent risk of hepatocellular …
antivirals (DAAs) leads to virological cure, however, the subsequent risk of hepatocellular …
[HTML][HTML] Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease
Methods This population-based cohort study from the Korean National Health Insurance
Service included 2003 to 2015 claims data collected from 1,209,825 patients aged≥ 40 …
Service included 2003 to 2015 claims data collected from 1,209,825 patients aged≥ 40 …
Surveillance of patients with cirrhosis remains suboptimal in the United States
Background & Aims Regular monitoring/surveillance for liver complications is crucial to
reduce morbidity and mortality in patients with cirrhosis. Recommendations from …
reduce morbidity and mortality in patients with cirrhosis. Recommendations from …
Cost-utility analysis of imaging for surveillance and diagnosis of hepatocellular carcinoma
PH Lima, B Fan, J Bérubé, M Cerny… - American Journal of …, 2019 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study is to compare imaging-based surveillance and
diagnostic strategies in patients at risk for hepatocellular carcinoma (HCC) while taking into …
diagnostic strategies in patients at risk for hepatocellular carcinoma (HCC) while taking into …